Eloxx Pharmaceuticals, Inc. (ELOX)

Eloxx Pharmaceuticals Analyst Ratings

ELOX's stock price has decreased by -89.93% in the past year and price targets may not have had time to catch up.

• Total Analysts: 1
• Consensus Rating: Buy
• Price Target: $55.00
• Upside: +6,465.60%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Hartaj Singh Oppenheimer	Oppenheimer	Buy Maintains $50 → $55	Buy	Maintains	$50 → $55	+6,465.60%	Jul 11, 2023
Hartaj Singh Oppenheimer	Oppenheimer	Buy Reiterates $50	Buy	Reiterates	$50	+5,868.72%	Apr 6, 2023
Edward Tenthoff Piper Sandler	Piper Sandler	Buy Maintains $160 → $60	Buy	Maintains	$160 → $60	+7,062.47%	May 23, 2022
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $40 → $20	Hold	Maintains	$40 → $20	+2,287.49%	May 9, 2022
Hartaj Singh Oppenheimer	Oppenheimer	Buy Initiates n/a	Buy	Initiates	n/a	n/a	Dec 17, 2021
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Nov 18, 2021
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Nov 11, 2021
Difei Yang Mizuho	Mizuho	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	Jun 30, 2021
Mayank Mamtani B. Riley Securities	B. Riley Securities	Strong Buy Initiates n/a	Strong Buy	Initiates	n/a	n/a	May 27, 2021
Joel Beatty Citigroup	Citigroup	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jun 11, 2020
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 6, 2020